Literature DB >> 3735524

Modifiers of calcium oxalate crystallization found in urine. III. Studies on the role of Tamm-Horsfall mucoprotein and of ionic strength.

D S Scurr, W G Robertson.   

Abstract

The effect was measured of incubating crystals of calcium oxalate monohydrate (COM) with 10 per cent normal urine and 10 per cent artificial urine on the surface zeta potential (ZP) produced on the crystals by various inhibitors of the agglomeration of COM. These studies showed that natural urine contains some constituent, not present in the artificial urine, which interferes with the ability of the inhibitors tested to produce a highly negative ZP on the crystal surface. A second series of studies showed that there are two factors in urine which modify the effect of the polyanionic inhibitors, Tamm-Horsfall mucoprotein (THM) and high ionic strength. At concentrations greater than 10(-8) mol./l., THM interfered with the binding of other polyanions to the surface of COM and reduced the maximum negativity of the ZP achievable on the crystals. This effect was very marked over the urinary concentration range (5 X 10(-8) to 6 X 10(-7) mol./l.; four to 48 mg./l.). By increasing the ionic strength of the incubation medium over the urinary range, the electrical double layer around the COM crystals was compressed and the interference caused by THM accentuated. Within most of the urinary range of ionic strength, THM interfered with the binding of other polyanions at concentrations greater than 10(-9) mol./l. In highly concentrated urine, at the top end of the urinary range of ionic strength, THM polymerized readily and to such an extent that it overwhelmed the inhibitors in urine and strongly promoted the agglomeration of COM crystals. The polymerization point of THM was found to be inversely related to the ionic strength of the solution in which it was dissolved.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3735524     DOI: 10.1016/s0022-5347(17)44931-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.

Authors:  Antonia Costa-Bauzá; Catalina Barceló; Juan Perelló; Felix Grases
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  The many roles of oxalate in nature.

Authors:  Lynwood H Smith
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

3.  Crystal morphology and texture in calcium oxalate monohydrate renal calculi.

Authors:  A Millan
Journal:  J Mater Sci Mater Med       Date:  1997-05       Impact factor: 3.896

Review 4.  Physico-chemical aspects of calcium stone formation.

Authors:  J M Baumann
Journal:  Urol Res       Date:  1990

5.  Effects of urinary macromolecules on the crystallization of calcium oxalate.

Authors:  H G Tiselius; A M Fornander; M A Nilsson
Journal:  Urol Res       Date:  1990

6.  Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls.

Authors:  J M Baumann; B Affolter; R Casella
Journal:  Urol Res       Date:  2011-05-13

7.  Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein.

Authors:  Pragasam Viswanathan; Jeffrey D Rimer; Ann M Kolbach; Michael D Ward; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urol Res       Date:  2011-01-13

Review 8.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

9.  Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone protein matrix.

Authors:  B Dussol; S Geider; A Lilova; F Léonetti; P Dupuy; M Daudon; Y Berland; J C Dagorn; J M Verdier
Journal:  Urol Res       Date:  1995

10.  Pathogenesis of bladder calculi in the presence of urinary stasis.

Authors:  M Adam Childs; Lance A Mynderse; Laureano J Rangel; Torrence M Wilson; James E Lingeman; Amy E Krambeck
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.